Voisard Asset Management Group, Inc. Abb Vie Inc. Transaction History
Voisard Asset Management Group, Inc.
- $240 Billion
- Q3 2024
A detailed history of Voisard Asset Management Group, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Voisard Asset Management Group, Inc. holds 536 shares of ABBV stock, worth $107,473. This represents 0.04% of its overall portfolio holdings.
Number of Shares
536
Previous 472
13.56%
Holding current value
$107,473
Previous $81 Million
30.75%
% of portfolio
0.04%
Previous 0.04%
Shares
4 transactions
Others Institutions Holding ABBV
# of Institutions
3,783Shares Held
1.28BCall Options Held
13MPut Options Held
9.82M-
Vanguard Group Inc Valley Forge, PA171MShares$34.2 Billion0.57% of portfolio
-
Black Rock Inc. New York, NY136MShares$27.4 Billion0.54% of portfolio
-
State Street Corp Boston, MA77.8MShares$15.6 Billion0.59% of portfolio
-
Jpmorgan Chase & CO New York, NY53.6MShares$10.7 Billion0.81% of portfolio
-
Capital International Investors Los Angeles, CA38.6MShares$7.74 Billion1.4% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $355B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...